In part 4 of this Exclusive Interview, Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the success of the geriatric patient with diabetes who needs to lose weight.
Read More »Yearly Archives: 2018
Ken Fujioka Part 5, Treating Diabetes With Weight Loss
In part 5 of this Exclusive Interview, Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about his philosophy for treating patients and what he's wants healthcare providers to take away from his presentation.
Read More »Ken Fujioka Part 6, The Future Of Weight Loss and Diabetes
In part 6, the conclusion of this Exclusive Interview, Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the potential treatments in development for weight issues and the growth of the discussion among today's healthcare providers.
Read More »Jan. 30, 2018
I was with about 10 other riders at breakfast recently. I happened to hear the word “diabetes” and of course my ears perked up. When I asked Russ and Randy what they were talking about, the subject was food choices and insulin resistance. Seems that one of them had heard …
Read More »Know Your Insulins, Teach Your Patient
Woman, 67 years of age, type 2 diabetes for 22 years, class II obesity. Has recently been managing her glucose levels with weight loss, using Tresiba, Trulicity, and metformin. Recent A1C 6.5%, which she’s worked hard for and been extremely proud of. She hasn’t had numbers like she has recently had for years.
Read More »Ray Kausik Part 5, PCSK9 Inhibitor Cost
In part 5 of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, CA about the cost of PCSK9 inhibitors in the U.S. versus Europe.
Read More »Framework for Understanding DM Part 6
In this week's Homerun Slides, understanding insulin resistance issues.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #110: Type 2 Diabetes and Cancer Part 3
Dyslipidemia: The relationship between cholesterol and cancer risk has been difficult to discern from epidemiologic studies. Individuals with the metabolic syndrome and T2DM frequently have a dyslipidemic profile with elevated triglycerides and decreased high-density lipoprotein cholesterol (HDL-C). In the Metabolic Syndrome Cancer (Me-Can) European cohort elevated triglyceride levels were associated with colon, respiratory, kidney, thyroid cancers, and melanoma in men and respiratory, cervical, and nonmelanoma skin cancers in women.
Read More »Jan. 27, 2018
The CDC and NIH are saying that this year is one of the worst ever for the flu. Patients often try OTC’s to treat the symptoms, but a lot of times respiratory problems drive them to their prescriber, and often a short course of tapering corticosteroid therapy is prescribed. This …
Read More »Fasting Glucose and Mortality
Study to examine the association between fasting glucose and mortality by age in patients with diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.